What does DR. MOTTRIE ALEXANDRE, UROLOOG do?

DR. MOTTRIE ALEXANDRE, UROLOOG is a specialist medical practice in Aalst. Private Limited, started on 14 January 2013, 1 establishment.

What is the address of DR. MOTTRIE ALEXANDRE, UROLOOG?

The registered office of DR. MOTTRIE ALEXANDRE, UROLOOG is located at Negen Dagwand 15, 9300 Aalst.

Is DR. MOTTRIE ALEXANDRE, UROLOOG still active?

Yes. According to the CBE (29 September 2026) DR. MOTTRIE ALEXANDRE, UROLOOG is active, legal situation “Normale toestand”, started on 14 January 2013.

Is DR. MOTTRIE ALEXANDRE, UROLOOG registered on Peppol?

Yes, DR. MOTTRIE ALEXANDRE, UROLOOG is registered on the Peppol network with ID 0208:0502420903.

What is the enterprise number of DR. MOTTRIE ALEXANDRE, UROLOOG?

The enterprise number of DR. MOTTRIE ALEXANDRE, UROLOOG is BE0502420903.

When was DR. MOTTRIE ALEXANDRE, UROLOOG founded?

DR. MOTTRIE ALEXANDRE, UROLOOG was founded on 14 January 2013.

Who are the directors of DR. MOTTRIE ALEXANDRE, UROLOOG?

According to the 2025 annual accounts, the directors of DR. MOTTRIE ALEXANDRE, UROLOOG are: Alexandre Mottrie.

Is DR. MOTTRIE ALEXANDRE, UROLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 January 2013; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. MOTTRIE ALEXANDRE, UROLOOG make in 2025?

DR. MOTTRIE ALEXANDRE, UROLOOG posted a profit after taxes of € 372,734 in financial year 2025.

What is the revenue of DR. MOTTRIE ALEXANDRE, UROLOOG?

As a small company, DR. MOTTRIE ALEXANDRE, UROLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 494,936.

DR. MOTTRIE ALEXANDRE, UROLOOG (Private Limited) - Aalst

Dossier DR. MOTTRIE ALEXANDRE, UROLOOG, printed on 29 September 2026 from databakkes.be/en/0502420903/dr-mottrie-alexandre-uroloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. MOTTRIE ALEXANDRE, UROLOOG from Aalst, company number BE0502420903, closed financial year 2025 with a result of € 372,734 after tax. For that financial year DR. MOTTRIE ALEXANDRE, UROLOOG recorded a gross margin of € 494,936 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 412,111 to € 372,734. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 1.7 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 372,734

▼ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 106,015

▲ 98% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 210,354 paid out

56 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 21,571

▲ 215% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 8,633

▼ 23% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 110,761

▲ 54% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 742,275 Gross margin 2022: € 742,275 First fiscal year in the series	€ 556,492 Gross margin 2023: € 556,492 ▼ 25% vs 2022 (€ 742,275) Unfavourable step	€ 472,869 Gross margin 2024: € 472,869 ▼ 15% vs 2023 (€ 556,492) Unfavourable step	€ 494,936 Gross margin 2025: € 494,936 ▲ 5% vs 2024 (€ 472,869) Favourable step	▲ 5%
Profit after taxes	€ 381,070 Profit after taxes 2022: € 381,070 First fiscal year in the series	€ 220,760 Profit after taxes 2023: € 220,760 ▼ 42% vs 2022 (€ 381,070) Unfavourable step	€ 412,111 Profit after taxes 2024: € 412,111 ▲ 87% vs 2023 (€ 220,760) Favourable step	€ 372,734 Profit after taxes 2025: € 372,734 ▼ 10% vs 2024 (€ 412,111) Unfavourable step	▼ 10%
Equity	€ 1,443,902 Equity 2022: € 1,443,902 First fiscal year in the series	€ 1,393,759 Equity 2023: € 1,393,759 ▼ 3% vs 2022 (€ 1,443,902) Unfavourable step	€ 1,526,513 Equity 2024: € 1,526,513 ▲ 10% vs 2023 (€ 1,393,759) Favourable step	€ 1,688,893 Equity 2025: € 1,688,893 ▲ 11% vs 2024 (€ 1,526,513) Favourable step	▲ 11%
Total debts	€ 96,642 Total debts 2022: € 96,642 First fiscal year in the series	€ 92,476 Total debts 2023: € 92,476 ▼ 4% vs 2022 (€ 96,642) Favourable step	€ 87,270 Total debts 2024: € 87,270 ▼ 6% vs 2023 (€ 92,476) Favourable step	€ 119,522 Total debts 2025: € 119,522 ▲ 37% vs 2024 (€ 87,270) Unfavourable step	▲ 37%
Cash	€ 142,989 Cash 2022: € 142,989 First fiscal year in the series	€ 137,929 Cash 2023: € 137,929 ▼ 4% vs 2022 (€ 142,989) Unfavourable step	€ 53,643 Cash 2024: € 53,643 ▼ 61% vs 2023 (€ 137,929) Unfavourable step	€ 106,015 Cash 2025: € 106,015 ▲ 98% vs 2024 (€ 53,643) Favourable step	▲ 98%
Retained profit	€ 1,431,502 Retained profit 2022: € 1,431,502 First fiscal year in the series	€ 1,381,359 Retained profit 2023: € 1,381,359 ▼ 4% vs 2022 (€ 1,431,502) Unfavourable step	€ 1,514,113 Retained profit 2024: € 1,514,113 ▲ 10% vs 2023 (€ 1,381,359) Favourable step	€ 1,676,493 Retained profit 2025: € 1,676,493 ▲ 11% vs 2024 (€ 1,514,113) Favourable step	▲ 11%
Dividend	€ 374,277 Dividend 2022: € 374,277 First fiscal year in the series	€ 270,903 Dividend 2023: € 270,903 ▼ 28% vs 2022 (€ 374,277) Unchanged	€ 279,358 Dividend 2024: € 279,358 ▲ 3% vs 2023 (€ 270,903) Unchanged	€ 210,354 Dividend 2025: € 210,354 ▼ 25% vs 2024 (€ 279,358) Unchanged	▼ 25%
Balance sheet total	€ 1,540,544 Balance sheet total 2022: € 1,540,544 First fiscal year in the series	€ 1,486,235 Balance sheet total 2023: € 1,486,235 ▼ 4% vs 2022 (€ 1,540,544) Unchanged	€ 1,613,783 Balance sheet total 2024: € 1,613,783 ▲ 9% vs 2023 (€ 1,486,235) Unchanged	€ 1,808,415 Balance sheet total 2025: € 1,808,415 ▲ 12% vs 2024 (€ 1,613,783) Unchanged	▲ 12%

Key figures of DR. MOTTRIE ALEXANDRE, UROLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. MOTTRIE ALEXANDRE, UROLOOG?

What happened at DR. MOTTRIE ALEXANDRE, UROLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 372,734 (▼ 10% vs 2024). filed late Source: NBB ↗
Jan 14, 2013 New establishment in Aalst. KBO
Jan 14, 2013 Start of the company according to the CBE. KBO

In short

From € 381,070 profit in 2022 to € 372,734 profit in 2025.

Paid € 639,684 in corporate taxes since 2022.

Best year ever: 2024, with € 412,111 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. MOTTRIE ALEXANDRE, UROLOOG? We notify you, reason included.

Follow DR. MOTTRIE ALEXANDRE, UROLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit